QT Population Modeling and Simulation Case Study
I wish I’d known earlier – five words you never want to hear
Hindsight is a marvellous thing. A healthy dose would take a lot of the risk out of drug research. Unfortunately, pharmaceutical and biopharmaceutical companies don’t have that luxury.
Millions are invested in potential drugs that will probably never make it to market. Financially unpredictable? Always. Financially rewarding? Occasionally. With company futures resting on effective clinical research, the importance of determining the most strategic Phase I/IIa study conducted by leading specialists shouldn’t be understated. Read more of this case study.